Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
NCT05646550
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer Recurrent
Interventions
DRUG:
CC-1 Infusion
Sponsor
University Hospital Tuebingen